ArticlePreventive medicine2015
Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates.
Article in Preventive medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed.
- Walking Improves Cardiac Function: A Trial on the Effects of Walking on Left Ventricular Function in Type 2 Diabetes Patients.Journal of cardiovascular development and disease · 2026Article
- The Beverage Quality Index and type 2 diabetes risk in women: a prospective analysis of the Mexican Teachers' Cohort.Nutrition & diabetes · 2026Article
- Birth-cohort patterns of e-cigarette and other tobacco use among adolescents in the US.Preventive medicine · 2024Article
- Using the illness-death model to estimate age- and sex-standardized incidence rates of diabetes in Mexico from 2003 to 2015.BMC public health · 2024Article
- Does a Reduction in Receiving Assistance With Daily Activities Among Older Adults in Mexico Indicate An Increase in Unmet Needs or a Decrease in Needs for Care?The journals of gerontology. Series B, Psychological sciences and social sciences · 2024Article
- Article
- Self-Reported Diabetes in Older Adults: A Comparison of Prevalence and Related Factors in the Mexican Health and Aging Study (2015, 2018, and 2021).Journal of diabetes research · 2024Article
- Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial.Microorganisms · 2023Article
- 'It is in our hands-Why wait until you are sick?': Perceptions about diabetes prevention of Latina mothers in Mexico and the United States.Diabetic medicine : a journal of the British Diabetic Association · 2023Article
- Caloric reductions needed to achieve obesity goals in Mexico for 2030 and 2040: A modeling study.PLoS medicine · 2023Article
- Trends of Antihypertensive, Antidiabetic, and Nonsteroidal Anti-Inflammatory Drugs Use among the Health Workers Cohort Study, Mexico 2004 to 2018.Advances in pharmacological and pharmaceutical sciences · 2023Article
- Factors Associated with Self-Report of Type 2 Diabetes Mellitus in Adults Seeking Dental Care in a Developing Country.International journal of environmental research and public health · 2022Article
- Comparative Analysis of Edentulism in a Sample of Mexican Adults with and without Type 2 Diabetes.Healthcare (Basel, Switzerland) · 2022Article
- Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032.International journal of environmental research and public health · 2022Article
- Trends and effect of marginalization on diabetes mellitus-related mortality in Mexico from 1990 to 2019.Scientific reports · 2022Article
- Liver cancer mortality in Mexico: trend analysis from 1998 to 2018.Salud publica de Mexico · 2022Article
- A comparison of rural-urban differences in out-of-pocket expenses among older Mexicans with diabetes.Frontiers in public health · 2022Article
- Article
- An Article in Two Parts: My Dinners With RichardDiabetes spectrum : a publication of the American Diabetes Association · 2022Article
- Age-specific rates of onset of cannabis use in Mexico.Addictive behaviors · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionMexico diabetes prevalence has increased dramatically in recent years. However, no national incidence estimates exist, hampering the assessment of diabetes trends and precluding the development of burden of disease analyses to inform public health policy decision-making. Here we provide evidence regarding current magnitude of diabetes in Mexico and its future trends.
methodsWe used data from the Mexico National Health and Nutrition Survey, and age-period-cohort models to estimate prevalence and incidence of self-reported diagnosed diabetes by age, sex, calendar-year (1960-2012), and birth-cohort (1920-1980). We project future rates under three alternative incidence scenarios using demographic projections of the Mexican population from 2010-2050 and a Multi-cohort Diabetes Markov Model.
resultsAdult (ages 20+) diagnosed diabetes prevalence in Mexico increased from 7% to 8.9% from 2006 to 2012. Diabetes prevalence increases with age, peaking around ages 65-68 to then decrease. Age-specific incidence follows similar patterns, but peaks around ages 57-59. We estimate that diagnosed diabetes incidence increased exponentially during 1960-2012, roughly doubling every 10 years. Projected rates under three age-specific incidence scenarios suggest diabetes prevalence among adults (ages 20+) may reach 13.7-22.5% by 2050, affecting 15-25 million individuals, with a lifetime risk of 1 in 3 to 1 in 2.
conclusionsDiabetes prevalence in Mexico will continue to increase even if current incidence rates remain unchanged. Continued implementation of policies to reduce obesity rates, increase physical activity, and improve population diet, in tandem with diabetes surveillance and other risk control measures is paramount to substantially reduce the burden of diabetes in Mexico.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.